Abstract
Sir,—In-the annotation on “Anti-Rh Serum Nomenclature” (Feb. 28, p. 400) you discuss the recent edict of the National Institute of Health in the United States regarding the labelling of anti-Rh sera, namely to use the earlier Wiener Rh-Hr system as standard, with the corresponding Fisher-Race C-D-E notations in parentheses. You regard this decision as a “transitional compromise,” implying that eventually the original notations will be abandoned in favour of the Fisher-Race system. However, this conclusion as well as the Board’s own analysis fails to take into account all the available facts.1 2 3 4 I have therefore prepared my own analysis of the situation, and after it is printed in your journal perhaps one of the C-D-E protagonists will attempt a reply. Only by publishing all the facts and both sides of every scientific problem can we ever hope to arrive at the correct solution.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
